I agree that this site is using cookies. You can find further informations here.
X
Robieson, Weining
98  results:
Search for persons X
?
1

Decision making in clinical trials: Interim analyses, innov..:

Welsh‐Bohmer, Kathleen A. ; Kerchner, Geoffrey A. ; Dhadda, Shobha...
Alzheimer's & Dementia: Translational Research & Clinical Interventions.  9 (2023)  4 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
2

Safety and Efficacy of 24-Hour/Day Subcutaneous Infusion of..:

Aldred, Jason ; Bergmans, Bruno ; Carroll, Camille...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
3

Efficacy and safety of foslevodopa/foscarbidopa versus oral..:

Facheris, Maurizio ; Robieson, Weining ; Fisseha, Nahome.
Journal of the Neurological Sciences.  429 (2021)  - p. 119569 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral..:

Facheris, Maurizio ; Robieson, Weining ; Fisseha, Nahome.
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
5

Sustained improvements in motor and non-motor symptoms in a..:

Chaudhuri, K. Ray ; Aldred, Jason ; Standaert, David...
Journal of the Neurological Sciences.  429 (2021)  - p. 119562 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Modified reference based imputation and tipping point analy..:

Jin, Man ; Liu, Ran ; Robieson, Weining
Contemporary Clinical Trials.  110 (2021)  - p. 106575 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Sustained Improvements in Motor and Non-Motor Symptoms in A..:

Aldred, Jason ; Standaert, David ; Kovacs, Norbert...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
8

Improvements in Dyskinesia with Levodopa-Carbidopa Intestin..:

Aldred, Jason ; Kovacs, Norbert ; Pontieri, Francesco...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
9

Lessons Learned From Multi-regional Trials With Signals of ..:

Li, Gang ; Quan, Hui ; Lan, Gordon...
Therapeutic Innovation & Regulatory Science.  54 (2020)  1 - p. 21-31 , 2020
Link: https://doi.org/10.1007/..
 
?
10

Application of the '5-2-1' Screening Criteria in Advanced P..:

Aldred, Jason ; Anca-Herschkovitsch, Marieta ; Antonini, Angelo...
Neurodegenerative Disease Management.  10 (2020)  5 - p. 309-323 , 2020
Link: https://doi.org/10.2217/..
 
?
11

Safety and Tolerability in Parkinson's Disease Patients Tre..:

Facheris, Maurizio ; Benesh, Janet ; Streit, Janet...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
12

Safety and Tolerability During a 4-Week Continuous Subcutan..:

Facheris, Maurizio ; Criswell, Susan ; Pavasia, Nirav...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
13

Statistical considerations in a delayed‐start design to dem..:

Wang, Deli ; Robieson, Weining ; Zhao, Jun..
Pharmaceutical Statistics.  18 (2019)  4 - p. 407-419 , 2019
Link: https://doi.org/10.1002/..
 
?
14

Lessons Learned From Multi-regional Trials With Signals of ..:

Li, Gang ; Quan, Hui ; Lan, Gordon...
Therapeutic Innovation & Regulatory Science.  , 2018
Link: https://doi.org/10.1177/..
 
?
15

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Ad..:

Zadikoff, Cindy ; Boyd, James ; Dubow, Stephanie...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
1-15